Identification of quinoline scaffolds against emerging drug target glycerophosphodiester phosphodiesterase from Staphylococcus aureus: an integrated in vitro, in silico, and STD-NMR approach.

RSC Adv · 2026 · PMC13330723 · PMID 42555402

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an interesting trendno p-value reported

Compounds 8–12 contain an electron-donating methyl group on the phenyl ring and showed an interesting trend in inhibitory activity.

also in 1,024 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Identification of quinoline scaffolds against emerging drug target glycerophosphodiester phosphodiesterase from &lt;i&gt;Staphylococcus aureus&lt;/i&gt;: an integrated &lt;i&gt;in vitro&lt;/i&gt;, &lt;i&gt;in silico&lt;/i&gt;, and STD-NMR approach.

The sentences

Identification of quinoline scaffolds against emerging drug target glycerophosphodiester phosphodiesterase from <i>Staphylococcus aureus</i>: an integrated <i>in vitro</i>, <i>in silico</i>, and STD-NMR approach.